Shenzhen Bioeasy Biotechnology Co., Ltd.
SZSE:300942.SZ
11.43 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 49.343 | 66.201 | 54.4 | 66.992 | 36.374 | 89.007 | 52.988 | 51.404 | 60.708 | 114.803 | 97.426 | 180.668 | 294.001 | 166.467 | 100.583 | 183.573 | 146.918 | 71.961 | 54.908 | 59.377 | 72.21 | 95.272 | 42.854 |
| Cost of Revenue
| 23.502 | 12.278 | 21.081 | 26.329 | 9.258 | 42.588 | 16.614 | 22.508 | 45.523 | 125.14 | 51.741 | 71.718 | 96.408 | 64.946 | 29.852 | 51.287 | 23.426 | 24.77 | 13.212 | 14.362 | 11.324 | 25.237 | 12.946 |
| Gross Profit
| 25.841 | 53.923 | 33.318 | 40.663 | 27.115 | 46.419 | 36.374 | 28.896 | 15.185 | -10.337 | 45.685 | 108.949 | 197.593 | 101.521 | 70.731 | 132.286 | 123.492 | 47.192 | 41.696 | 45.015 | 60.885 | 70.035 | 29.907 |
| Gross Profit Ratio
| 0.524 | 0.815 | 0.612 | 0.607 | 0.745 | 0.522 | 0.686 | 0.562 | 0.25 | -0.09 | 0.469 | 0.603 | 0.672 | 0.61 | 0.703 | 0.721 | 0.841 | 0.656 | 0.759 | 0.758 | 0.843 | 0.735 | 0.698 |
| Reseach & Development Expenses
| 8.239 | 11.648 | 8.683 | 8.186 | 10.281 | 4.534 | 8.102 | 22.116 | 18.392 | 50.873 | 19.82 | 25.119 | 15.606 | 26.694 | 15.558 | 19.49 | 10.69 | 9.984 | 11.631 | 10.478 | 8.37 | 10.215 | 6.115 |
| General & Administrative Expenses
| 10.41 | -23.313 | 29.628 | -6.145 | 12.772 | -37.776 | 34.388 | 13.172 | 13.981 | 4.117 | 50.456 | 12.508 | 23.386 | -15.513 | 25.743 | -3.641 | 12.611 | 3.221 | 30.756 | -20.24 | 5.982 | -46.877 | 5.309 |
| Selling & Marketing Expenses
| 11.595 | -11.176 | 24.115 | 13.484 | 9.732 | 3.746 | 13.651 | 22.734 | 16.622 | 3.93 | 16.644 | 19.451 | 18.52 | 16.421 | 8.095 | 13.739 | 9.825 | 6.009 | 10.047 | 9.944 | 6.236 | 12.535 | 7.003 |
| SG&A
| 22.005 | -34.489 | 53.743 | 28.376 | 21.958 | -34.03 | 48.038 | 35.906 | 30.602 | 13.844 | 67.099 | 31.96 | 41.906 | 0.908 | 33.839 | 10.098 | 22.435 | 9.23 | 40.802 | -10.296 | 12.218 | -34.342 | 12.312 |
| Other Expenses
| 0.625 | 60.866 | -35.319 | 0 | 0.013 | -1.344 | -0.95 | -0.293 | 0.091 | 0 | -0.003 | 0.015 | 0.028 | -6.005 | -0.262 | 0.013 | 6.017 | -0.035 | 2.691 | -3.819 | 0.001 | -2.895 | -0.198 |
| Operating Expenses
| 30.869 | 38.026 | 27.107 | 37.726 | 32.238 | 36.485 | 36.938 | 72.901 | 47.404 | 64.19 | 61.02 | 75.776 | 55.096 | 52.851 | 33.702 | 43.428 | 30.101 | 22.88 | 25.659 | 33.939 | 19.767 | 26.101 | 16.16 |
| Operating Income
| -5.028 | 15.897 | 6.212 | 6.198 | -5.123 | -80.215 | -11.293 | -50.259 | -33.534 | -87.182 | -8.541 | 45.297 | 139.28 | 44.25 | 41.234 | 87.282 | 95.511 | 16.123 | 13.422 | 4.646 | 40.914 | 44.252 | 14.952 |
| Operating Income Ratio
| -0.102 | 0.24 | 0.114 | 0.093 | -0.141 | -0.901 | -0.213 | -0.978 | -0.552 | -0.759 | -0.088 | 0.251 | 0.474 | 0.266 | 0.41 | 0.475 | 0.65 | 0.224 | 0.244 | 0.078 | 0.567 | 0.464 | 0.349 |
| Total Other Income Expenses Net
| -0.006 | -0.928 | -0.254 | -0.107 | -0.047 | -54.913 | -0.819 | -0.293 | 0.091 | 5.992 | 5.03 | 8.636 | 2.89 | 8.278 | 3.036 | 0.903 | 6.099 | -4.564 | 1.673 | 5.206 | -0.203 | 5.762 | -0.198 |
| Income Before Tax
| -5.035 | 14.97 | 5.957 | 6.092 | -5.17 | -81.559 | -12.244 | -50.552 | -33.443 | -81.19 | -8.544 | 45.312 | 139.308 | 38.245 | 40.972 | 87.295 | 101.528 | 16.088 | 13.419 | 3.521 | 40.915 | 44.284 | 14.755 |
| Income Before Tax Ratio
| -0.102 | 0.226 | 0.11 | 0.091 | -0.142 | -0.916 | -0.231 | -0.983 | -0.551 | -0.707 | -0.088 | 0.251 | 0.474 | 0.23 | 0.407 | 0.476 | 0.691 | 0.224 | 0.244 | 0.059 | 0.567 | 0.465 | 0.344 |
| Income Tax Expense
| -0.801 | 1.338 | 1.017 | 0.771 | -0.056 | 4.208 | 17.297 | -8.961 | -5.358 | 15.562 | -5.477 | 8.051 | 25.21 | -2.593 | 8.631 | 11.603 | 13.928 | 2.548 | 0.707 | -0.654 | 5.893 | 6.201 | 1.682 |
| Net Income
| -3.346 | 13.22 | 5.456 | 5.552 | -7.111 | -85.749 | -29.526 | -41.571 | -28.061 | -65.399 | -3.049 | 37.285 | 114.129 | 40.846 | 32.353 | 75.698 | 87.61 | 13.55 | 12.681 | 4.184 | 35.031 | 38.087 | 13.081 |
| Net Income Ratio
| -0.068 | 0.2 | 0.1 | 0.083 | -0.195 | -0.963 | -0.557 | -0.809 | -0.462 | -0.57 | -0.031 | 0.206 | 0.388 | 0.245 | 0.322 | 0.412 | 0.596 | 0.188 | 0.231 | 0.07 | 0.485 | 0.4 | 0.305 |
| EPS
| -0.008 | 0.032 | 0.014 | 0.014 | -0.018 | -0.22 | -0.074 | -0.1 | -0.07 | -0.17 | -0.008 | 0.093 | 0.28 | 0.1 | 0.079 | 0.19 | 0.23 | 0.04 | 0.032 | 0.013 | 0.09 | 0.11 | 0.04 |
| EPS Diluted
| -0.008 | 0.032 | 0.014 | 0.014 | -0.018 | -0.22 | -0.074 | -0.1 | -0.07 | -0.17 | -0.008 | 0.093 | 0.28 | 0.1 | 0.079 | 0.19 | 0.23 | 0.04 | 0.032 | 0.013 | 0.09 | 0.11 | 0.04 |
| EBITDA
| 3.911 | 21.557 | 9.76 | 18.162 | -1.935 | -35.117 | -5.183 | -34.8 | -32.263 | -84.316 | 3.115 | 53.194 | 147.17 | 48.169 | 49.828 | 94.072 | 108.111 | 18.431 | 14.965 | 5.122 | 42.883 | 43.934 | 11.533 |
| EBITDA Ratio
| 0.079 | 0.326 | 0.179 | 0.271 | -0.053 | -0.395 | -0.098 | -0.677 | -0.531 | -0.734 | 0.032 | 0.294 | 0.501 | 0.289 | 0.495 | 0.512 | 0.736 | 0.256 | 0.273 | 0.086 | 0.594 | 0.461 | 0.269 |